Kolding

Denmark

40 total trials 25 recruiting

Filter these 40 trials by phase, condition, sponsor and more.

Open in Search →

Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 6 2020-08-24 Fluid overload/fluid accumulation
A research study to investigate the effects of CagriSema compared to placebo in people with type 2 diabetes and painful diabetic peripheral … Ended recruitment

2023-509662-38-00 4 2025-01-22 Type 2 diabetes and painful diabetic peripheral neuropathy
StayDry Ended recruitment

2023-510280-35-00 6 2024-05-27 Daytime urinary incontinence
REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended recruitment

2023-506924-94-00 5 2023-02-28 Cardiovascular disease
Bicarbonate for the treatment of cardiac arrest Ended recruitment

2022-501304-10-00 6 2023-02-06 In-hospital cardiac arrest
Efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis Ended recruitment

2023-504597-37-00 5 2022-03-25 Focal segmental glomerulosclerosis
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended recruitment

2023-506926-35-00 5 2021-09-24 Atherosclerotic cardiovascular disease, chronic kidney disease and sys
Non-inferiority study of ocrelizumab and rituximab in active multiple sclerosis Ended recruitment

2024-514287-84-00 5 2021-04-28 Multiple sclerosis
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized … Ended

2023-504487-41-00 5 2023-11-28 COVID-19
Orchid 1 Ended

2023-503516-32-00 4 2023-10-12 Vulvar lichen sclerosus (VLS)
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran … Ended

2023-503793-20-00 5 2023-01-18 Prevention of ischemic stroke in patients post acute non-cardioembolic
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis … Ended

2023-503794-38-00 5 2022-11-24 Prevention of stroke or systemic embolism in atrial fibrillation
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 5 2019-05-24 Adults at high risk of cardiovascular events without prior MI or strok
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 5 2018-12-01 Myocardinal infarction
Effectiveness and Safety of Sparsentan as treatment for Primary Focal Segmental Glomerulosclerosis (FSGS) Ended

2023-505494-32-00 5 2018-10-15 Focal segmental glomerulosclerosis (FSGS)
DANHEART Ended

2024-514212-27-00 5 Heart failure

Showing 25–40 of 40 trials